Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer - A Southwest Oncology Group study

Stephen K. Williamson, John Crowley, Robert B. Livingston, Geoffrey Weiss

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer - A Southwest Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences